Cerebrovascular Disease in COVID-19

Area of Science:

• Neurology
• Infectious Diseases
• Public Health

Background:

• Transmissible illnesses have historically shown associations with cerebrovascular disease.
• The emergence of SARS-CoV-2 (the virus causing COVID-19) presents an unprecedented risk for stroke.
• The COVID-19 pandemic has altered healthcare practices and disease epidemiology.

Purpose of the Study:

• To review the history and impact of the COVID-19 pandemic on cerebrovascular disease.
• To summarize lessons learned in managing patients with cerebrovascular disease during the pandemic.

Main Methods:

• This study is a narrative review.
• It synthesizes existing literature on SARS-CoV-2 and cerebrovascular disease.
• It discusses adaptations in medical care and treatment practices.

Main Results:

• SARS-CoV-2 demonstrates a stronger association with acute cerebrovascular disease than previously observed viral infections.
• The pandemic has led to significant shifts in stroke epidemiology.
• Healthcare systems adapted treatment to mitigate transmission and address diagnostic delays.

Conclusions:

• The association between SARS-CoV-2 and cerebrovascular events is historically significant.
• The COVID-19 pandemic necessitated adaptive strategies in managing stroke patients.
• Lessons learned are crucial for future public health crises impacting neurological care.